Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: PharmaCyte Biotech Inc., 2 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
PharmaCyte Biotech Inc. March 30, 202690.6%
-
PharmaCyte Biotech Inc. April 24, 202593.0%
-
PharmaCyte Biotech Inc. April 29, 202473.2%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 12, 2025 | PharmaCyte Biotech Inc. | Grant or award | +37,500 | — | — |
| Dec 12, 2025 | PharmaCyte Biotech Inc. | Shares withheld for tax | −16,875 | $1.02 | $17,213 |
Questions about Michael M. Abecassis
What boards is Michael M. Abecassis on?
Michael M. Abecassis sits on the board of PharmaCyte Biotech Inc.
How long has Michael M. Abecassis served on boards?
Our records show at least 3 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.